Hemispherx Biopharma (HEB) Reports Q3 Loss of $0.30/Share
Tweet
Share
E-mailGet Alerts HEB Hot Sheet
Price: $1.80 --0%
Financial Fact:
Research and development: 900K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Research and development: 900K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Hemispherx Biopharma (NYSE: HEB) reported Q3 EPS of ($0.30), versus ($0.62) reported last year.
For earnings history and earnings-related data on Hemispherx Biopharma (HEB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- Ubiquiti (UI) Tops Q4 EPS by 25c, Beats on Revenue
- RenovoRx regains Nasdaq minimum bid price compliance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
